Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel radical amino migration patent enables mild benzolactam synthesis. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Novel DES-mediated synthesis of benzoxazine derivatives offers green, high-yield routes for pharmaceutical intermediates, reducing costs and environmental impact.
Novel carbonylation method using sulfonyl chlorides avoids toxic thiols. High purity thioesters for pharma intermediates with simplified supply chain.
Advanced organocatalytic route for chiral indoxazinone compounds offering high enantioselectivity and scalable manufacturing for pharmaceutical intermediates.
Patent CN110590781B reveals a novel Pd-catalyzed asymmetric allylic amination route for high-purity antiviral intermediates, offering significant cost reduction and scalable manufacturing capabilities.
Novel copper-catalyzed method for cyclopentenone derivatives offers high yield and mild conditions. Ideal for pharmaceutical intermediates supply chain optimization and cost reduction.
Discover the novel Sc(OTf)3-catalyzed synthesis of indole-derived piperidines. A cost-effective, high-yield route for anticancer pharmaceutical intermediates with superior diastereoselectivity.
Patent CN113307778A details a novel Mo/Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering mild conditions and high efficiency for reliable pharmaceutical intermediate supply.
Patent CN115057848B reveals mild synthesis for high-purity pharmaceutical intermediates. Achieve substantial cost reduction and enhanced supply chain reliability.
Novel Pd-catalyzed method for 2-alkynyl indoles using water solvent. Enhances supply chain reliability and reduces environmental impact for pharma intermediates.
Novel synthesis method using chiral phosphoric acid. High yield, mild conditions. Reliable supply for pharma intermediates. Cost effective manufacturing solution.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral pyrroles with high enantioselectivity and cytotoxic activity against QGP-1 cells.
Patent CN118126005B reveals metal-free synthesis for fluorinated heterocycles. Enables cost reduction and scalable supply for pharmaceutical intermediates manufacturing.
Novel Mo/Cu co-catalyzed method offers mild conditions and high yields for critical heterocyclic scaffolds used in drug discovery.
Patent CN110452150B reveals a novel organocatalytic route for high-purity axial chiral indole-naphthalene synthesis, offering significant cost reduction and supply chain reliability.
Patent CN105622537A reveals a metal-free synthesis for 3,4,5-trisubstituted isoxazoles. Discover cost-effective, scalable pharmaceutical intermediate manufacturing solutions.
Patent CN117720537B reveals novel catalyst enabling high-purity asymmetric synthesis with reduced costs and scalable supply chain reliability for global buyers.
Patent CN113307790B reveals a metal-free oxidative cyclization route for 1,2,4-triazoles, offering significant cost reduction in API manufacturing and simplified supply chains.
Patent CN114524701B reveals a novel organocatalytic route for N-N axis chiral pyrroles with high cytotoxicity, offering cost-effective API intermediate manufacturing solutions.
Patent CN101503358A details a novel organocatalytic route using Lappaconitine for chiral intermediates, offering safer processing and reduced metal contamination risks.